|
1
|
Sigel CS, Drill E, Zhou Y, Basturk O,
Askan G, Pak LM, Vakiani E, Wang T, Boerner T, Do RKG, et al:
Intrahepatic cholangiocarcinomas have histologically and
immunophenotypically distinct small and large duct patterns. Am J
Surg Pathol. 42:1334–1345. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Banales JM, Marin JJG, Lamarca A,
Rodrigues PM, Khan SA, Roberts LR, Cardinale V, Carpino G, Andersen
JB, Braconi C, et al: Cholangiocarcinoma 2020: The next horizon in
mechanisms and management. Nat Rev Gastroenterol Hepatol.
17:557–588. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bridgewater J, Galle PR, Khan SA, Llovet
JM, Park JW, Patel T, Pawlik TM and Gores GJ: Guidelines for the
diagnosis and management of intrahepatic cholangiocarcinoma. J
Hepatol. 60:1268–1289. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Conway AM, Morris GC, Smith S, Vekeria M,
Manoharan P, Mitchell C, Backen A, Oliveira P, Hubner RA, Lamarca
A, et al: Intrahepatic cholangiocarcinoma hidden within cancer of
unknown primary. Br J Cancer. 127:531–540. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sirica AE, Gores GJ, Groopman JD, Selaru
FM, Strazzabosco M, Wei Wang X and Zhu AX: Intrahepatic
cholangiocarcinoma: Continuing challenges and translational
advances. Hepatology. 69:1803–1815. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Raoof M and Singh G: Rising trends in
intrahepatic cholangiocarcinoma incidence and mortality: Getting at
the root cause. Hepatobiliary Surg Nutr. 8:301–303. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Florio AA, Ferlay J, Znaor A, Ruggieri D,
Alvarez CS, Laversanne M, Bray F, McGlynn KA and Petrick JL: Global
trends in intrahepatic and extrahepatic cholangiocarcinoma
incidence from 1993 to 2012. Cancer. 126:2666–2678. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Varadhachary GR: Carcinoma of unknown
primary origin. Gastrointest Cancer Res. 1:229–235. 2007.PubMed/NCBI
|
|
9
|
Oda E, Hashimoto D, Shiomi Y, Ohnishi K,
Hayashi H, Chikamoto A, Takeya M and Baba H: A case of occult
intrahepatic cholangiocarcinoma diagnosed by autopsy. Surg Case
Rep. 1:1012015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nozaki Y, Yamamoto M, Ikai I, Yamamoto Y,
Ozaki N, Fujii H, Nagahori K, Matsumoto Y and Yamaoka Y:
Reconsideration of the lymph node metastasis pattern (N factor)
from intrahepatic cholangiocarcinoma using the International Union
Against Cancer TNM staging system for primary liver carcinoma.
Cancer. 83:1923–1929. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chung YE, Kim MJ, Park YN, Choi JY, Pyo
JY, Kim YC, Cho HJ, Kim KA and Choi SY: Varying appearances of
cholangiocarcinoma: Radiologic-pathologic correlation.
RadioGraphics. 29:683–700. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Martin SP, Drake J, Wach MM, Ruff SM,
Diggs LP, Wan JY, Good ML, Dominguez DA, Ayabe RI, Glazer ES, et
al: Resection and chemotherapy is the optimal treatment approach
for patients with clinically node positive intrahepatic
cholangiocarcinoma. HPB (Oxford). 22:129–135. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Amin MB, Greene FL, Edge SB, Compton CC,
Gershenwald JE, Brookland RK, Meyer L, Gress DM, Byrd DR and
Winchester DP: American Joint Committee on Cancer, American Cancer
Society: AJCC cancer staging manual. 8th edition. American Joint
Committee on Cancer; Chicago, IL: 2017
|
|
14
|
Yamamoto M, Takasaki K and Yoshikawa T:
Lymph node metastasis in intrahepatic cholangiocarcinoma. Jpn J
Clin Oncol. 29:147–150. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Martin SP, Ruff S, Diggs LP, Drake J,
Ayabe RI, Brown ZJ, Wach MM, Steinberg SM, Davis JL and Hernandez
JM: Tumor grade and sex should influence the utilization of portal
lymphadenectomy for early stage intrahepatic cholangiocarcinoma.
HPB (Oxford). 21:419–424. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
de Jong MC, Nathan H, Sotiropoulos GC,
Paul A, Alexandrescu S, Marques H, Pulitano C, Barroso E, Clary BM,
Aldrighetti L, et al: Intrahepatic cholangiocarcinoma: An
international multi-institutional analysis of prognostic factors
and lymph node assessment. J Clin Oncol. 29:3140–3145. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Jutric Z, Johnston WC, Hoen HM, Newell PH,
Cassera MA, Hammill CW, Wolf RF and Hansen PD: Impact of lymph node
status in patients with intrahepatic cholangiocarcinoma treated by
major hepatectomy: A review of the National Cancer Database. HPB
(Oxford). 18:79–87. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang XF, Xue F, Dong DH, Weiss M, Popescu
I, Marques HP, Aldrighetti L, Maithel SK, Pulitano C, Bauer TW, et
al: Number and station of lymph node metastasis after
curative-intent resection of intrahepatic cholangiocarcinoma impact
prognosis. Ann Surg. 274:e1187–e1195. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jolissaint JS, Soares KC, Seier KP, Kundra
R, Gönen M, Shin PJ, Boerner T, Sigel C, Madupuri R, Vakiani E, et
al: Intrahepatic cholangiocarcinoma with lymph node metastasis:
Treatment-Related outcomes and the role of tumor genomics in
patient selection. Clin Cancer Res. 27:4101–4108. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yamamoto M, Takasaki K, Yoshikawa T, Ueno
K and Nakano M: Does gross appearance indicate prognosis in
intrahepatic cholangiocarcinoma? J Surg Oncol. 69:162–167. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ohtsuka M, Ito H, Kimura F, Shimizu H,
Togawa A, Yoshidome H and Miyazaki M: Results of surgical treatment
for intrahepatic cholangiocarcinoma and clinicopathological factors
influencing survival. Br J Surg. 89:1525–1531. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Shimada K, Sano T, Sakamoto Y, Esaki M,
Kosuge T and Ojima H: Surgical outcomes of the mass-forming plus
periductal infiltrating types of intrahepatic cholangiocarcinoma: A
comparative study with the typical mass-forming type of
intrahepatic cholangiocarcinoma. World J Surg. 31:2016–2022. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang Y, Li J, Xia Y, Gong R, Wang K, Yan
Z, Wan X, Liu G, Wu D, Shi L, et al: Prognostic nomogram for
intrahepatic cholangiocarcinoma after partial hepatectomy. J Clin
Oncol. 31:1188–1195. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Utada M, Ohno Y, Tamaki T, Sobue T and
Endo G: Long-term trends in incidence and mortality of intrahepatic
and extrahepatic bile duct cancer in Japan. J Epidemiol.
24:193–199. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kubo S, Shinkawa H, Asaoka Y, Ioka T,
Igaki H, Izumi N, Itoi T, Unno M, Ohtsuka M, Okusaka T, et al:
Liver Cancer Study Group of Japan Clinical Practice Guidelines for
Intrahepatic Cholangiocarcinoma. Liver Cancer. 11:290–314. 2022.
View Article : Google Scholar : PubMed/NCBI
|
